Arunaya Organics Board of Directors
Get the latest insights into the leadership at Arunaya Organics. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Vinod Brijmohandas Agrawal | Chairman & Managing Director |
| Mrs. Shivali Vinod Agrawal | Executive Director |
| Mr. Ashokbhai Divanchand Agrawal | Non Executive Director |
| Mr. Umesh Krishnankutty Menon | Ind. Non-Executive Director |
| Ms. Amita Chhaganbhai Pragada | Ind. Non-Executive Director |
Arunaya Organics Share price
ARUNAYA
19.9
0.00 (0.00%)Last updated on 31 Dec, 2025 | 15:31 IST
BUYSELL
Today's High
20.55
Today's Low
19.15
52 Week Low
17.50
52 Week High
46.50
The current prices are delayed, login to your account for live prices
Login Arunaya Organics FAQs
The board at Arunaya Organics consists of experienced professionals, including Mr. Vinod Brijmohandas Agrawal , Mrs. Shivali Vinod Agrawal , and others, overseeing the company’s strategic and corporate governance.
Directors at Arunaya Organics are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Vinod Brijmohandas Agrawal is the current chairman at Arunaya Organics.
Executive directors at Arunaya Organics are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Arunaya Organics adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Arunaya Organics, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
